Status:
COMPLETED
School Adolescent Mood Project: Efficacy of IPT-AST in Schools
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Institute of Education Sciences
Conditions:
Depressive Symptoms
Eligibility:
All Genders
14-75 years
Phase:
NA
Brief Summary
This school-based randomized controlled trial will: a) examine the effects of telehealth-administered Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST), an evidence-based depression pre...
Detailed Description
This is a randomized clinical trial. Adolescents with elevated depressive symptoms will be identified and randomly assigned to IPT-AST delivered through telehealth by research staff (alone or in colla...
Eligibility Criteria
Inclusion
- Adolescent Participants
- Adolescents in 9th or 10th grade between the ages of 14 and 17
- Adolescent must be English-speaking; parents must be English or Spanish-speaking
- Parental/guardian permission (informed consent) and child assent/consent
- A score of 16 or higher on the CES-D AND at least 2 threshold or subthreshold symptoms on the K-SADS-PL
- Have access to a cellular phone, computer, and/or tablet and have internet access to complete the remote intervention and evaluations
Exclusion
- Less than 2 threshold or subthreshold symptoms on the K-SADS-PL
- Significant current active suicidal ideation reported on the K-SADS-PL at the eligibility evaluation or suicide attempt in the past year reported on the K-SADS-PL at the eligibility evaluation
- Significant cognitive or language impairments requiring placement in Special Education as reported by the parent or as evident in the eligibility evaluation
- Youth may be excluded on a case-by-case basis if the eligibility/baseline evaluation suggests that the group program would not be appropriate (for, instance, in the case of significant behavioral problems in the baseline evaluation).
- For Parent Participants
- Inclusion Criteria:
- Parents of students in 9th or 10th grade between the ages of 14 and 17 at one of the participating schools
- English or Spanish-speaking or limited English proficiency with use of interpreter
- Consent to participate
- Have access to a phone, computer, and/or tablet to complete remote evaluations
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2024
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT04109716
Start Date
August 15 2019
End Date
December 2 2024
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hopsital of Philadelphia
Philadelphia, Pennsylvania, United States, 19146